Further research is needed to elucidate the role of rare LDLR variants, e.g., evaluating lipid deposition in iPSc‐based AMD/EODM model systems, or measuring cholesterol levels in blood of patients with rare variants in LDLR. This evidence concerns the gene LDLR and age-related macular degeneration.